The genetic architecture of tumors induced by high and low energy radiation in Trp53 deficient mice Feb. 12, 2020
Health Canada clears Bold to begin phase Ib study of BOLD-100 in gastrointestinal cancers Feb. 11, 2020
Boehringer Ingelheim studies BI-905681 in phase I for advanced, unresectable or metastatic tumors Feb. 7, 2020
RSS